Metabolic Reprogramming in Arginine Deiminase-Resistant Cells

نویسندگان

  • Yan Long
  • Wen-Bin Tsai
  • Medhi Wangpaichitr
  • Takashi Tsukamoto
  • Niramol Savaraj
  • Lynn G. Feun
  • Macus Tien Kuo
  • L. G. Feun
چکیده

Authors’ Affiliations: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; Department of Neurology and Brain Science Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland *These authors contributed equally Corresponding Author: Macus Tien Kuo, Ph.D. Department of Translational Molecular Pathology, Unit 951, Room 2SCR4.3025, The University of Texas MD Anderson Cancer Center, 7435 Fannin Blvd, Houston, TX 77054; Tel: 713-834-6038, Fax: 713-834-6085; E-mail: [email protected] Running Title: Metabolic Reprogramming in Arginine Deiminase-Resistant Cell

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction.

Many malignant human tumors, including melanomas, are auxotrophic for arginine due to reduced expression of argininosuccinate synthetase-1 (ASS1), the rate-limiting enzyme for arginine biosynthesis. Pegylated arginine deiminase (ADI-PEG20), which degrades extracellular arginine, resulting in arginine deprivation, has shown favorable results in clinical trials for treating arginine-auxotrophic t...

متن کامل

Cancer Therapeutics Insights Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction

Many malignant human tumors, including melanomas, are auxotrophic for arginine due to reduced expression of argininosuccinate synthetase-1 (ASS1), the rate-limiting enzyme for arginine biosynthesis. Pegylated arginine deiminase (ADI-PEG20), which degrades extracellular arginine, resulting in arginine deprivation, has shown favorable results in clinical trials for treating arginine-auxotrophic t...

متن کامل

Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo.

The strategy of enzymatic degradation of amino acids to deprive malignant cells of important nutrients is an established component of induction therapy of acute lymphoblastic leukemia. Here we show that acute myeloid leukemia (AML) cells from most patients with AML are deficient in a critical enzyme required for arginine synthesis, argininosuccinate synthetase-1 (ASS1). Thus, these ASS1-deficie...

متن کامل

Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line.

Two kinds of growth-inhibitory substances were found in culture of a Rous sarcoma virus-transformed rat liver cell line, RSV-BRL. The two substances were purified from the serum-free culture medium and identified as transforming growth factor beta 1 and Mycoplasma-derived arginine deiminase (EC 3.5.3.6), respectively. The arginine deiminase was an acid-labile but dithiothreitol-resistant protei...

متن کامل

Potent Growth Inhibition of Human Tumor Cells in Culture by Arginine Deiminase Purified from a Culture Medium of a Mycoplasma-infected Cell Line1

Two kinds of growth-inhibitory substances were found in culture of a Rous sarcoma virus-transformed rat liver cell line, RSV-BRL. The two substances were purified from the serum-free culture medium and iden tified as transforming growth factor ß, and Mycoplasma-áerÃ-\edarginine deiminase (EC 3.5.3.6), respectively. The arginine deiminase was an acidlabile but dithiothreitol-resistant protein ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2013